Scientific Library
Cancer Immunotherapy: Generate your PD-L1 target cell line
In a recent post,  I invited you to discover a cell line provided by BPS Bioscience over-expressing the checkpoint
New research tools targeting PCSK9 and LDLR
There is an increasing demand for new cholesterol-lowering therapies in addition to existing treatments (e.g. targeting statins). The pharmacological inhibition of PCSK9-mediated LDLR degradation
Screen for inhibitors of PD-1 signalling with a complete cellular assay system
Immunotherapy represents a field in Drug Discovery which is quickly developing and leading to significant progress in treatments of a number of diseases, especially cancer. The approach is based on inducing,
How to produce high yield capped mRNA
Messenger RNA can be used for protein expression into the cells. The delivery of mRNA is the delivery of a new function that can activate a biological process. In the particular case of the CAS9 mRNA,
New cancer treatment may reawaken the immune system
Cancer is a disease caused by abnormal cell growth. The cells’ genetic material is corrupted and the metabolic processes do not interact well with them anymore. They grow unchecked, mostly in the form
Peptide applications in biomedicine - harnessing Nanotechnology power
Peptide advances in biomedicine
Peptides, which are short chains of amino acids, have gained significant attention in biomedicine due to their diverse applications. Their unique properties, such as high